Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001683168-23-003408
Filing Date
2023-05-15
Accepted
2023-05-15 16:28:20
Documents
15
Period of Report
2023-03-08
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT AMENDMENT 1 acon_8ka1.htm   iXBRL 8-K/A 35978
2 AUDITOR LETTER FROM DASZKAL BOLTON LLP DATED MAY 12, 2023 acon_ex1601.htm EX-16.1 2530
3 AUDITOR LETTER FROM COHNREZNICK LLP DATED MAY 12, 2023 acon_ex1602.htm EX-16.2 2394
  Complete submission text file 0001683168-23-003408.txt   263638

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE acon-20230308.xsd EX-101.SCH 3993
5 XBRL DEFINITION FILE acon-20230308_def.xml EX-101.DEF 26648
6 XBRL LABEL FILE acon-20230308_lab.xml EX-101.LAB 36765
7 XBRL PRESENTATION FILE acon-20230308_pre.xml EX-101.PRE 25272
9 EXTRACTED XBRL INSTANCE DOCUMENT acon_8ka1_htm.xml XML 5556
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41358 | Film No.: 23923043
SIC: 8071 Services-Medical Laboratories